Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Pharmacogenomics Market?

The market size of pharmacogenomics has seen a quick expansion in the past years. The growth is projected to increase from $8.94 billion in 2024 to $9.92 billion in 2025, having a compound annual growth rate (CAGR) of 10.9%. The previous development has been propelled by robust economic advancements in developing markets, a heightened emphasis on tailor-made medication, improvement in sophisticated healthcare infrastructure and a rise in healthcare spending.

What Growth Rate Is Forecasted for the Pharmacogenomics Market by 2029?

In the coming years, the pharmacogenomics market is projected to experience swift expansion and is predicted to reach a value of $14.81 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.5%. The significant growth during the forecast period can be attributed to factors such as an increasing elderly population, rising chronic illnesses, population growth and greater demand for cancer treatments. Key trends projected for the forecast period encompass the launch of genome editing solutions for more in-depth analysis of sophisticated therapies, a focus on integrating artificial intelligence (AI) in genomics for genetic data analysis, and continued advancements in metagenomics. Other factors include strategic alliances and cooperation between market participants, the introduction of 3D genomics for studying the impacts on gene expression and function, novel product innovations with an emphasis on infectious diseases and gene editing, as well as the development of psychotropic pharmacogenomics tests to aid informed decisions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7072&type=smp

Which Key Companies Are Shaping the Future of the Pharmacogenomics Market?

Major companies operating in the pharmacogenomics market include Illumina Inc, Eurofins Scientific, Myriad Genetics Inc, PerkinElmer Inc, Centogene N.V, Invitae Corporation, Genomind, Pacific Biosciences of California Inc, Oneome LLC, Admera Health, MapMyGenome, Positive Bioscience, Xcode Life Sciences, Xcelris Labs, Takeda Pharmaceutical Company Limited, Garvan Institute of Medical Research, 3D Medicines Inc, Berry Genomics, BGI, GenomiCare Biotechnology, Bayer AG, GlaxoSmithKline plc (GSK), F Hoffmann-La Roche AG, Merck KGaA, QIAGEN N.V, Centro de Genoma e Biologia de Sistemas (CGBS), Dasa Group, Datar Cancer Genetics Limited, MedGenome Labs, 23andMe, Color Genomics, Pathway Genomics, Laboratório Richet, Laboratório Exame, Genomika Diagnósticos

Which Factors Are Driving Demand in the Pharmacogenomics Industry?

The escalating need for personalized medicine is fueling the pharmacogenomics market’s growth rate. This healthcare approach revolves around customized medical treatments, practices, decisions, or products, focusing on a specific group of patients rather than an all-encompassing drug-for-all model. The demand for such individualized medication has seen a rise, especially in oncology, with broader and more promising roles beyond merely cancer and late-stage ailments like unique and genetic disorders. The central objective of precision medicine is to amalgamate genetic and environmental specifics related to particular diseases or their responses to certain remedies. For instance, a Linchpinseo article from March 2022 states that big pharmaceutical companies’ investment in precision medicine is expected to rise by one-third over the next five years. Additionally, precision medication, with its tailor-made treatment, is coming to the aid of 30 million individuals suffering from type 2 diabetes in the USA, which will overhaul conventional treatment protocols. As a result, the burgeoning need for precision medicine is set to catalyze the pharmacogenomics market’s expansion.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7072&type=smp

How Is the Pharmacogenomics Market Segmented by Several Divisions?

The pharmacogenomics market covered in this report is segmented –

1) By Technology: Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, Other Technologies

2) By Application: Neurological Diseases, Infectious Diseases, Oncology, Cardiovascular Diseases, Pain Management, Other Applications

3) By End User: Hospitals and Clinics, Research Institutions, Academic Institutes, Other End Users

Subsegments:

1) By Next Generation Sequencing (NGS): Whole Genome Sequencing, Targeted Sequencing, Exome Sequencing

2) By Polymerase Chain Reaction (PCR): Quantitative PCR (qPCR), Reverse Transcription PCR (RT-PCR), Digital PCR

3) By Gel Electrophoresis: Agarose Gel Electrophoresis, Polyacrylamide Gel Electrophoresis, Capillary Gel Electrophoresis

4) By Mass Spectrometry: LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry), MALDI-TOF MS (Matrix-Assisted Laser Desorption/Ionization Time of Flight), HRMS (High-Resolution Mass Spectrometry)

5) By Microarray: SNP Microarrays, Expression Microarrays, Comparative Genomic Hybridization (CGH) Arrays

6) By Other Technologies: Sanger Sequencing, CRISPR-Based Technologies, Bioinformatics Tools

What are the Emerging Market Trends Driving the Growth of the Pharmacogenomics Industry?

A key trend emerging in the pharmacogenomics market is the advancement of technology. Pharmaceutical manufacturers are concentrating on different methods of pharmacogenomics analysis in order to offer affordable options for screening identified polymorphisms and identifying new variations. In May 2022, for example, Invitae, a medical laboratory organization based in the United States, introduced its broader Pharmacogenomics Panel. The Invitae Pharmacogenomics (PGx) Panel, which includes the Mental Health Panel, provides information on how genetics affect medication responses across several specialties such as primary care, cardiology, and oncology. Given that nearly 25% of patients exhibit unusual drug reactions due to their genetic makeup, PGx testing is poised to become a routine procedure. However, a comprehensive integration into healthcare necessitates improved provider support for comprehending and implementing PGx testing in their clinical contexts.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

Which Regions Are Driving Growth in the Pharmacogenomics Market?

North America was the largest region in the pharmacogenomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7072

This Report Delivers Insight On:

1. How big is the pharmacogenomics market, and how is it changing globally?

2. Who are the major companies in the pharmacogenomics market, and how are they performing?

3. What are the key opportunities and risks in the pharmacogenomics market right now?

4. Which products or customer segments are growing the most in the pharmacogenomics market?

5. What factors are helping or slowing down the growth of the pharmacogenomics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model